GCL
AVNR

Glazer Capital LLC’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Glazer Capital LLC’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,004,815
Closed -$17M – 100
2014
Q4 		$17M Buy
+1,004,815
New +$14.1M 2.46% 17

Glazer Capital LLC's AVNR Position: Q1 2015 in Review

Glazer Capital LLC sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,004,815 shares — an estimated $17M sold.

Glazer Capital LLC first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $17M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Glazer Capital LLC reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Glazer Capital LLC sold 1,004,815 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $17M.
  • Glazer Capital LLC first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Glazer Capital LLC's AVANIR PHARMACEUTICALS, INC CL A position peaked at $17M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Glazer Capital LLC's 13F filing for Q1 2015, filed 15 May 2015.